COMPASS Pathways Plc

COMPASS Pathways plc

Financials113 views1 min read

COMPASS Pathways plc to announce third quarter 2021 financial results on 9 November 2021

COMPASS Pathways plc
London, U.K., Nov. 08, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the third quarter 2021, and provide an update on recent business developments, on 9 November 202... Read More...
Financials922 views17 min read

COMPASS Pathways plc announces financial results and business highlights for the second quarter 2021

COMPASS Pathways plc
Highlights:Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021Partnership being developed with leading UK institutions to accelerate psychedelic research and develop new models of mental health care in the UKGuy Goodwin appointed Chief Medical Offi... Read More...
CalendarFinancials52 views1 min read

COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021

COMPASS Pathways plc
London, UK, Aug. 04, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2021, and provide an update on recent business developments, on 11 August 2021.... Read More...
Featured61 views5 min read

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

COMPASS Pathways plc
LONDON, June 03, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, has reported further results from a phase I study showing that its COMP360 psilocybin had no clinically-relevant negative effect on cognitive functio... Read More...
47 views4 min read

Correction: COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways plc
COMPASS Pathways establishes Centre of Excellence with Sheppard Prattto accelerate research and improve patient experience in mental health careLondon, UK – 8 January 2021COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, is ... Read More...
Featured51 views4 min read

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways plc
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!